Skip to content
Search

Latest Stories

Fatal fungus threat could expand globally due to climate change, warn researchers

The fungus can grow quickly in heat

Fatal fungus
Aspergillus species pose serious risks to human health and agriculture
iStock

A potentially deadly fungus that spreads rapidly and is resistant to treatment may become more widespread as global temperatures rise, according to new research.

The fungus, Aspergillus, is known to cause infections in humans, animals and plants. It thrives in warmer environments, and scientists now warn that climate change is creating more suitable conditions for its growth. The findings, based on a pre-print study from the University of Manchester, indicate that global warming could accelerate the spread of dangerous strains such as Aspergillus flavus and Aspergillus fumigatus.


The University of Manchester, which hosts the world’s largest centre for research into fungi and respiratory infections, stated in the report that Aspergillus species pose serious risks to human health and agriculture. Viv Goosens, research manager at the Wellcome Trust – which funded the study – told Sky News that fungal pathogens are already a concern, and climate change will make these risks worse. “To address these challenges, we must fill important research gaps,” she said.

The analysis suggests that by the year 2100, Aspergillus flavus, which affects crops, could expand its range by up to 16%. Meanwhile, Aspergillus fumigatus, a fungus that causes lung infections particularly in people with asthma or other underlying conditions, could increase its geographical spread by as much as 77%.

The U.S. Centers for Disease Control and Prevention identifies Aspergillus fumigatus as the leading cause of invasive mould infections in humans. The fungus causes a disease known as aspergillosis, which can be fatal and is often resistant to antifungal treatments. According to the CDC, patients infected with Aspergillus fumigatus are 33% more likely to die compared to those with treatable infections.

The fungus can grow quickly in heat, exacerbating the impact of global warming. Professor Elaine Bignell, co-director of the MRC Centre for Medical Mycology at Exeter University, told the Financial Times that the fungus develops “astonishingly quickly” in high temperatures.

Dr Norman van Rhijn, lead author of the study and a research fellow at the University of Manchester, warned that major shifts in the distribution of fungi could occur over the next few decades. “We’re talking about hundreds of thousands of lives, and continental shifts in species distributions,” he told the Financial Times. “In 50 years, where things grow and what you get infected by is going to be completely different.”

The research has drawn comparisons to the fictional fungal apocalypse portrayed in the popular series The Last of Us. However, Dr van Rhijn cautioned against viewing the findings as mere science fiction. “Reality is already scary enough,” he told Sky News.

Aspergillosis, the disease caused by inhaling fungal spores, can lead to symptoms such as fatigue, headaches, coughing up blood, and in severe cases, the infection can spread throughout the body. Scientists say that without further research and global mitigation efforts, fungal threats like Aspergillus could become increasingly difficult to control.

More For You

weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
Weight Loss Drug

Health officials expect the rollout to benefit around 220,000 adults over the next 3 years

iStock

NHS GPs to prescribe Mounjaro in nationwide obesity treatment plan

Key points

  • NHS GPs in England can now prescribe Mounjaro (tirzepatide) for weight loss
  • The programme aims to support 220,000 people over three years
  • Eligible patients must have a BMI over 40 and at least four obesity-related health issues
  • GP leaders raise concerns over increased workload
  • Pharmacists urge a broader weight management approach

NHS expands obesity treatment with Mounjaro

The NHS in England is set to begin prescribing Mounjaro, a weight loss injection, through GP surgeries starting Monday. The move marks the first time family doctors will be authorised to directly prescribe the anti-obesity drug tirzepatide as part of a wider national health initiative.

Health officials expect the rollout to benefit around 220,000 adults over the next three years. The drug will be made available to those with a body mass index (BMI) above 40 who also suffer from at least four other obesity-related conditions, such as type 2 diabetes, high blood pressure, or sleep apnoea.

Keep ReadingShow less
UK heatwave deaths

Around 85% of the projected deaths are likely to involve people over the age of 65

iStock

Scientists warn current UK heatwave may cause nearly 600 early deaths

Almost 600 premature deaths are expected to occur during the ongoing heatwave affecting England and Wales, according to a new rapid analysis by leading scientists. The majority of fatalities are projected among older adults, with London and the West Midlands likely to be the worst-affected areas.

Climate change driving deadly temperatures

Researchers say the extreme temperatures, which have reached 32°C in parts of south-east England, would have been nearly impossible without the influence of human-caused climate change. Pollution from burning fossil fuels has raised the likelihood of such heatwaves by around 100 times, experts say.

Keep ReadingShow less
Amycretin

'The Lancet' and presentations at the American Diabetes Association’s 2025

iStock

New weight-loss pill Amycretin shows greater impact than jabs, study finds

A new weight-loss drug, amycretin, has delivered the most significant results yet for appetite-suppressing GLP-1 medications, according to two newly published studies in The Lancet and presentations at the American Diabetes Association’s 2025 Scientific Sessions in Chicago.

Record weight loss from Amycretin injections

Researchers found that participants receiving high-dose weekly injections of amycretin lost 24.3 per cent of their body weight over 36 weeks. This outcome surpasses the results seen in longer trials involving other GLP-1 drugs such as tirzepatide (sold as Mounjaro), which previously led the field with an average weight loss of 20 per cent over 72 weeks.

Keep ReadingShow less
Hulk Hogan

Hogan’s current hospital stay follows a neck fusion surgery he underwent in May 2025

Getty Images

Hulk Hogan hospitalised for back and neck issues, rep confirms he is not on deathbed

WWE Hall of Famer Hulk Hogan has been hospitalised for ongoing neck and back issues, but representatives have confirmed he is not in critical condition, dismissing online speculation suggesting otherwise.

The 71-year-old wrestling icon, whose real name is Terry Bollea, was reported by TMZ Sports to be undergoing treatment related to injuries sustained during his decades-long in-ring career. His representative said Hogan is already mobile again and “not on his deathbed”, following false claims made on air by Florida radio personality Bubba the Love Sponge.

Keep ReadingShow less